Product
REX-001
1 clinical trial
6 indications
Indication
Peripheral Arterial DiseaseIndication
Diabetes MellitusIndication
Type 1Indication
Type 2Indication
Cardiovascular DiseaseIndication
Critical Limb IschemiaClinical trial
The Efficacy and Safety of Intra-arterial Administration of REX-001 to Treat Ischemic Ulcers in Subjects With Critical Limb Ischemia (CLI) Rutherford Category 5 and Diabetes Mellitus: A Pivotal, Placebo-controlled, Double-blind, Parallel-group, Adaptive TrialStatus: Terminated, Estimated PCD: 2023-02-13